Clinical Trial Update: A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that HT-101 and HT-102 are being studied in Phase 1/Phase 2 for chronic hepatitis B, and the trial status is ACTIVE_NOT_RECRUIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HT-101
• HT-102

Snippet

Sponsor: Suzhou HepaThera Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING